Bio Startup Nexo Lands $60M to Climb to New Heights in Cancer Drug R&D

Nexo Therapeutics is developing cancer drugs that expand the scope of amino acids addressable by covalent chemistry. Versant Ventures founded the startup and led its Series A financing.